Tina Moore

And the reason I got interested in them originally was because of their neuroprotective benefits. That was what got me looking at them. And when I started finding the data in both rodents and humans, I was like, what? This is not what we're being told. And beyond that, yes, they have a very incredible...

And the reason I got interested in them originally was because of their neuroprotective benefits. That was what got me looking at them. And when I started finding the data in both rodents and humans, I was like, what? This is not what we're being told. And beyond that, yes, they have a very incredible...

And the reason I got interested in them originally was because of their neuroprotective benefits. That was what got me looking at them. And when I started finding the data in both rodents and humans, I was like, what? This is not what we're being told. And beyond that, yes, they have a very incredible...

I believe if you break down the mechanisms, I just did a podcast about TERS appetite and metabolic health overall. They look to be protective of metabolic health. They definitely induce weight loss. I don't think it's just because they get you to eat less. I think it's because they actually improve your insulin signaling, your insulin reception. There's a lot of different mechanisms going on here.

I believe if you break down the mechanisms, I just did a podcast about TERS appetite and metabolic health overall. They look to be protective of metabolic health. They definitely induce weight loss. I don't think it's just because they get you to eat less. I think it's because they actually improve your insulin signaling, your insulin reception. There's a lot of different mechanisms going on here.

I believe if you break down the mechanisms, I just did a podcast about TERS appetite and metabolic health overall. They look to be protective of metabolic health. They definitely induce weight loss. I don't think it's just because they get you to eat less. I think it's because they actually improve your insulin signaling, your insulin reception. There's a lot of different mechanisms going on here.

They impact the immune system directly and indirectly. They lower inflammation in the brain and throughout the body. All of these things will help with overall cardioprotective benefits, weight loss, neurologic benefits. I mean, they're pretty profound.

They impact the immune system directly and indirectly. They lower inflammation in the brain and throughout the body. All of these things will help with overall cardioprotective benefits, weight loss, neurologic benefits. I mean, they're pretty profound.

They impact the immune system directly and indirectly. They lower inflammation in the brain and throughout the body. All of these things will help with overall cardioprotective benefits, weight loss, neurologic benefits. I mean, they're pretty profound.

So the interpretation here was GLP-1 receptor agonists may offer neuroprotection beyond their cardiovascular benefits, potentially through anti-inflammatory antioxidant and anti-apoptotic mechanisms, that's programmed cell death, at the neuronal level. SGLT2s might have a neuroprotective potential, but data so far does not show a statistically significant dementia risk reduction.

So the interpretation here was GLP-1 receptor agonists may offer neuroprotection beyond their cardiovascular benefits, potentially through anti-inflammatory antioxidant and anti-apoptotic mechanisms, that's programmed cell death, at the neuronal level. SGLT2s might have a neuroprotective potential, but data so far does not show a statistically significant dementia risk reduction.

So the interpretation here was GLP-1 receptor agonists may offer neuroprotection beyond their cardiovascular benefits, potentially through anti-inflammatory antioxidant and anti-apoptotic mechanisms, that's programmed cell death, at the neuronal level. SGLT2s might have a neuroprotective potential, but data so far does not show a statistically significant dementia risk reduction.

Importantly, while observational studies suggested possible benefits, this meta-analysis only showed a statistically significant dementia reduction for GLP-1 receptor agonists, not the other drugs that they looked at. The conclusion was only the GLP-1 receptor agonists demonstrated a statistically significant reduction in risk for all-cause dementia. This is really exciting.

Importantly, while observational studies suggested possible benefits, this meta-analysis only showed a statistically significant dementia reduction for GLP-1 receptor agonists, not the other drugs that they looked at. The conclusion was only the GLP-1 receptor agonists demonstrated a statistically significant reduction in risk for all-cause dementia. This is really exciting.

Importantly, while observational studies suggested possible benefits, this meta-analysis only showed a statistically significant dementia reduction for GLP-1 receptor agonists, not the other drugs that they looked at. The conclusion was only the GLP-1 receptor agonists demonstrated a statistically significant reduction in risk for all-cause dementia. This is really exciting.

It's not entirely that groundbreaking if you've been looking at the data though. I get a lot of hate for talking about this peptide and I don't understand why because its neurocognitive impacts are profound. I did a whole podcast episode with Max Lugavere on his Genius Life podcast and we talked specifically about the neurocognitive benefits and I shared some pretty great data there.

It's not entirely that groundbreaking if you've been looking at the data though. I get a lot of hate for talking about this peptide and I don't understand why because its neurocognitive impacts are profound. I did a whole podcast episode with Max Lugavere on his Genius Life podcast and we talked specifically about the neurocognitive benefits and I shared some pretty great data there.

It's not entirely that groundbreaking if you've been looking at the data though. I get a lot of hate for talking about this peptide and I don't understand why because its neurocognitive impacts are profound. I did a whole podcast episode with Max Lugavere on his Genius Life podcast and we talked specifically about the neurocognitive benefits and I shared some pretty great data there.

Oh, gosh, an eight-page lesson inside my GLP-1 Done Right University. It's an educational program. It's my big course. I have a free four-part video series where you can check out if this is new to you and you're like, wait, what? Ozempic may potentially have these other impacts on the body. getting away from brand name drugs, just GLP-1 agonists in general.

Oh, gosh, an eight-page lesson inside my GLP-1 Done Right University. It's an educational program. It's my big course. I have a free four-part video series where you can check out if this is new to you and you're like, wait, what? Ozempic may potentially have these other impacts on the body. getting away from brand name drugs, just GLP-1 agonists in general.